Copyright
©The Author(s) 2024.
World J Clin Pediatr. Jun 9, 2024; 13(2): 92737
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.92737
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.92737
Aspect | Purine metabolism | Pyrimidine metabolism |
Functions | Building blocks for nucleic acid synthesis; Metabolic signals; Provide energy; Regulate cell growth; Participate in coenzymes; Contribute to sugar transport; Donate phosphate groups in phosphorylation reactions | Synthesizing DNA and RNA; Energy metabolism; Neurotransmitter signaling |
Specific roles | Provide energy for membrane-active pumps like Na+/K+ ATPase; Vital for sustaining synaptic transmission; Facilitate collaboration between neurons and glial cells | Biosynthesis of polysaccharides and phospholipids; Participate in detoxification processes; Contribute to protein and lipid glycosylation |
Impact on brain function | Altered purine metabolism may impact brain function and contribute to ASD symptoms; Adenosine acts as a neuromodulator, inhibiting neurotransmitter release and regulating sleep-wake cycles | Abnormalities in pyrimidine metabolism may be linked to ASD and neurodevelopmental issues; Disturbances in uracil metabolism could contribute to mitochondrial dysfunction in ASD |
Potential biomarkers | Elevated adenosine levels and altered ADA activity observed in ASD; Abnormal levels of purine metabolites such as uric acid reported in ASD | Altered uracil levels and abnormal ratios of uracil to other pyrimidine bases reported in ASD; Abnormal levels of pyrimidine nucleotides observed in ASD |
Genetic | Mutations in genes encoding enzymes involved in purine metabolism found in individuals with ASD | Genetic mutations in the gene encoding DPD identified in individuals with ASD |
Therapeutic implications | Modulating adenosine signaling and targeting enzymes involved in purine metabolism could potentially improve neurochemical functioning in ASD | Supplementation with pyrimidine precursors such as uridine was explored as a possible intervention to improve mitochondrial function and neurodevelopmental outcomes in ASD |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Metabolomic changes in children with autism. World J Clin Pediatr 2024; 13(2): 92737
- URL: https://www.wjgnet.com/2219-2808/full/v13/i2/92737.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v13.i2.92737